Metabolic issues: Feeling constantly cold, chills, or a low body temperature (signs of metabolic acidosis) Severe gastrointestinal changes: Persistent diarrhea, vomiting, or a total loss of appetite Systemic changes: Unexplained tiredness, a fever or other signs of infection, unusual bleeding, bruising, or long-term concerns like osteoporosis In general, higher doses of topiramate are associated with an increased risk of adverse reactions
The results here highlight the role of GLP-1 RAs may play as a catalyst for earlier diagnosis and intervention in metabolic and related conditions
C., Camisa, C., Cheney, P., Pacula, C
We are seeing more options, new mechanisms, and levels of efficacy that were unimaginable just a few years ago, including oral therapies and medications approaching weight loss previously seen only with surgery
Gastrointestinal symptoms including nausea, vomiting, and diarrhea are most common, particularly during dose escalation
For those participating in retatrutide clinical trials, managing side effects is an important part of the treatment experience